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The Nova Stat Profile 1 analyser, a combined sodium, potassium,
ionized calcium, haematocrit and conventional blood gas analyser,
was evaluated over a four month period. In addition to assessing
and demonstrating that the instrument met analytical requirements,
an appreciation of the use of ionised calcium (iCa) was made.
Prospective costs were characterised and practical problems ofiCa
measurement addressed.
The performance of the Nova Stat Profile (NSP1) was
evaluated over a period of four months. The instrument
measures pH, pCO2, pO2, haematocrit (hct), barometric
pressure. Calculated parameters include total CO2,
actual bicarbonate, oxygen content, standard bicarbo-
Inate, base excess (ecf/blood), haemoglobin, oxygen
saturation and normalized ionized calcium.
There is particular interest in the measurement ofiCa as
a clinically valuable addition in determining calcium
status correctly [1]. Standard methods of automated
analysis of total calcium (tCa) use dye-binding tech-
niques, and have been shown to have limitations as a
discriminant in patients with disorders of calcium
homeostasis [2]. The inclusion ofiCa measurement with
blood gas analysis offers a potential solution to the
introduction ofiCa measurement, as it combines similar-
ity of specimen requirements for both tests [3]. Evalua-
tion of the NSP1 provided the opportunity to investigate
aspects of iCa measurement, such as sample handling
and the effect of the ratio of anticoagulant to sample [4].
The usefulness of iCa measurement in conjunction with
blood gas, hct and other electrolyte measurement was
also reviewed. Projected costs were characterized for
varying workloads.
Description of the instrument
The NSP1 is shown in figure 1. Its dimensions are 56.3 cm
deep by 56.3 cm wide by 46.1 cm high. It weighs 45 kg
and has three major component areas: (1) a microproces-
sor, screen and keyboard; (2) a centrally placed fluids
deck with reagent pack, and below it, the printer unit;
and (3) the analytical compartment, which contains the
electrodes, the barometric pressure module and temper-
ature regulation device. The electrodes are of the flow-by
design, and are arranged in the following order:
Reference electrode solid state electrode
Na+ sodium ion-selective electrode glass
K+ valinomycin ion-exchange membrane
iCa neutral carrier membrane electrode
pH hydrogen ion-selective electrode glass
pCO Severinghaus-type electrode
pO polarographic Clark-type electrode
hct impedance electrode.
1 CRT Display
2 Keypad
3 Printer
4 Reagent Pack
5 Sampling Inlet
6 Analytical Compartment
7 Fluids Deck
Correspondence to Dr Peter Frost. Figure 1. Nova Stat Profile 1.
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Any determination may be made on its own or in ’mini
profile’ groups. Sample type may be venous or arterial
whole blood, plasma, serum or expired gases.
Materials and methods
The NSP1 was supplied by the manufacturers (Nova
Biomedical, Corsham, UK) and installed by the U.K.
agent (Clandon Scientific Ltd, Aldershot, Hampshire,
UK) who also provided a back-up service. The NSP1 was
operated throughout according to the manufacturer’s
instructions. Manufacturer’s control materials, both
aqueous and protein-based, were use’d to evaluate within-
and between-day imprecision and bias.
Within-day imprecision was measured by 20 replicate
analyses of the sodium, potassium, iCa and pH, pCO2
and pO2 at three levels on the aqueous control material;
sodium, potassium and iCa were also analysed by 20
replicate analyses at three levels on the protein-based
control material. Hct was measured by 20 replicate
analyses on the manufacturer’s control material at two
levels. The manufacturer’s instructions were strictly
followed- aqueous material was shaken for 10 s, opened
and used within 60 s. Protein-based material was gently
mixed, opened and used within 48 h, having been stored
at 4C during this time.
Between-day imprecision was evaluated by measuring
controls (as described above) in triplicate daily for 20
days.
Bias was evaluated with similar materials as those used
for within- and between-day imprecision. Between-day
imprecision and bias for blood gases were also evaluated
by thin film tonometry, using an IL237 tonometer
(Instrumentation Laboratories, Warrington, UK). This
instrument was used and maintained as recommended by
the manufacturers. Blood gases at two levels (high and
low) were measured in triplicate for 20 days. Concentra-
tions of gases at the high level were pCO 13.5%, pO
13.9% of the total (remainder nitrogen), and at the low
level were pCO 7.32%, pO 6.8% of the total
(remainder nitrogen). Sample preparation was standar-
dized as follows. 5 ml of whole blood from a lithium
heparin collection tube was added to the sample cuvette
and placed in the tonometer for at least 5 min to attain
temperature equilibration. The equilibrating gas was
bubbled through the tonometer at a flow rate of 300
ml/min to saturate the chamber. Whole blood was then
tonometered for 10 min to ensure complete saturation at
the same gas flow rate. A ml syringe (Insulin type) was
used to sample the blood. Sample transfer to the NSP1
was minimized by priming the instrument to sample
immediately after withdrawal from the tonometer.
While the sample was being measured on the NSP1,
tonometry was continued on the IL237, until three
samples had been measured for each gas level. For each
observed result the theoretical result was calculated for
that day’s barometric pressure, and the observed result
was then corrected to standard barometric pressure (760
mmHg). Between-day imprecision and bias were then
obtained from these corrected values.
Patient sample comparison
Correlation with existing methods
Blood gases
61 patient arterial whole blood samples collected into
Pulsator syringes (Concord Laboratories Ltd, Folkstone,
UK, sodium heparin content 150 U.S.P. units) were
assayed for pH, pCO2 and pO, firstly on a Corning 168
(Corning Medical & Scientific, Halstead, UK) and then,
in all cases within 2 min, on the NSP1.
Haematocrit
148 patient samples collected into Na2 E.D.T.A. contain-
ers were assayed, over a period of five consecutive days.
The samples were selected from those run on the previous
day on a Technicon H6000 (Technicon, Basingstoke,
UK), to cover as wide a range of values as possible.
Sodium and potassium
197 patient samples ofplasma obtained from whole blood
collected into lithium heparin containers were assayed for
sodium and potassium on the Beckman Astra 4 (Beck-
man, High Wycombe, UK). 150 were then assayed on the
same day on the NSP1.47 samples were selected since the
Na+ and/or K+ values were outside the appropriate
reference range (sodium 135-145 mmol/1 and potassium
3"5-5"0 mmol/1). These samples were frozen and stored at
-20C; when thawed they were mixed gently, centri-
fuged for 5 min at an RCF of 850 g (Beckman Tabletop
centrifuge TH4 rotor with buckets). They were then
decanted into sample cups, reassayed for sodium and
potassium on the Astra 4 and immediately thereafter, on
the NSP1.
Statistical analysis
Linear regression analysis by the method ofDeming was
performed on the data obtained from comparative
analyses [5].
Ionized calcium
Length oftime prior to assay
Blood for serum and plasma samples, taken consecutively
without stasis were either placed in chilled water,
centrifuged for 5 min as above, at 4C and analysed
immediately, or were left for different time intervals and
then centrifuged as above prior to analysis. All sample
bottles were filled to within cm of the top to minimize
the effect of carbon dioxide loss [6]. iCa values were
corrected for a pH of 7.40 (NSP1 printout as ’nCa//’).
These specimens were then analysed for tCa on the ERIS
analyser (BDH, Poole, UK), using an o-cresol-phthalein-
complexone method (ERIS kit, BDH), coefficient of
variation 2.5%.
Effect ofanticoagulant
Different sample volumes of venous blood were taken in
Pulsator syringes from which all the visible sodium
heparin solution had been expelled. 150 1 remain in the
’dead space’- i.e. 150 U.S.P. units of heparin sodium
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(Concord Laboratories Ltd). iCa, sodium and potassium
were measured on these samples.
Patient samples
Samples were analysed for iCa and tCa (method as
above) from 14 patients who were hypercalcaemic
(reference ranges: iCa 0"80-1.20 mmol/1, tCa 2"20-2"60
mmol/1). The samples were either arterial whole blood or
plasma. The latter was from blood that had been taken
into lithium heparin containers filled to capacity, centri-
fuged and measured within 2 h. iCa values were corrected
to a pH of 7.40 for comparison.
Bias
Within-day: using the manufacturer’s control material, all
parameters were within the target values for the materials
at all levels for both aqueous and protein-based
standards.
Between-day: all parameter means were within the target
values for all materials at all levels except for pH on
aqueous material (level 2). Later information from the
manufacturer indicated that this was not an isolated
observation, and that other users had found a consistently
higher value than the quoted target. Between-day bias,
calculated from tonometry data is also shown in table 1.
Costs
Running costs during the evaluation were divided by the
number of samples analysed. Projected basic costs for
running the instrument per annum outside warranty, for
maintenance only, were calculated. Maintenance costs
were calculated from manufacturer’s schedule for preven-
tive maintenance and include conditioning and cleaning
solutions, electrolyte solutions, replacement harness tub-
ing, membraning kits and fan filter replacements. Prices
were itemized from the list supplied by the UK distribu-
tor in January 1987.
User appraisal
A full appraisal of the machine was made. A record of
daily electrode slopes was kept and daily maintenance of
the machine was performed as recommended by the
manufacturers. A variety of staff (MLSO and junior
medical) were taught how to use the instrument. The
machine had to be re-sited three times during the
evaluation due to relocation of the department at that
time.
Results
Imprecision
The results are shown in table 1. Between-day coefficients
ofvariation (CVs) are represented by the range of results
observed across three control levels.
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Figure 2. Effect oflength oftime prior to assay on ionized calcium.
Table 1. Imprecision. (Manufacturer’s control material," observed range at three control levels).
Within-day
Analyte level 2 3
Between-day
level 2
pH (s.d.) 0"002 0.004 0-004
pCOg 1.01 1"07 1-87
pO2 2"54 0"82 1.05
Na+ 0"28 0"44 0"50
K+ 0"71 0"70 1-14
iCa 0-78 2"30 2"53
hct 1"59 0"99
TONOMETRY (n 60)
between-day CV %
Low gas High gas
pCO2 4"3 4.1
pO 4’9 1’7
Actual
52"19
48"48
CV%
0"010 0"010 0"011
4"8 4"4 5"3
3"1 2"O 2"9
0"8 0"7 0"7
0"9 1"0 1’3
2"6 2"0 3"5
3-3 1"0
bias (mm Hg)
Low gas
Observed mean Actual
52"95 96’26
47"76 99"11
High gas
Observed mean
97"34
96"23
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Table 2. Patient sample comparison. (y A + Bx, wherey NSP1 method, x as below).
R quoted by
A B R X Nova*
pH -0" 1474 1"0207 0"931 Corning 168 0-993
pCO2 -0"8043 1.0805 0’973 0"998
pO2 2"6136 1"025 0’996 0"997
Na+ 3"2119 0"997 0"948 Beckman Astra 4 0"991
K+ -0"0511 1"045 0"990 1"006"*
hct 0"5649 0"9444 0"902 Technicon H6000 0"998
* From The Future ofBlood Gas (Nova leaflet). Comparison methods not quoted for Na+, K+ and hct. Nova comparison instrument for
blood gases (Corning 178).
** This figure as published by Nova.
Calcium
Effect of length of time prior to assay
iCa levels fell markedly after one hour (see figure 2).
There was no significant difference in tCa levels.
Anticoagulant effect
iCa levels decreased as anticoagulant to sample propor-
tion increased. There was a similar, smaller effect on the
potassium levels (see figure 3).
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Figure 3. Varying ratio of sample: anticoagulant. Effect on
electrolytes.-
Note: When all visible sodium heparin is expelled from the
Pulsator syringe, there is still 150 1 remaining in the
’dead space’- i.e. 150 U.S.P. units of heparin sodium
remain (Concord Laboratories Ltd).
Patient samples
iCa and tCa levels are compared in figure 4 showing
relative difference from the reference range for both
(identical scale). Student’s t-test showed a significant
difference (p <0.05) when values over the upper limit
of normal for each reference range were compared.
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Figure 4. Total and ionized calcium- varying relation to upper
limit of reference ranges in 14 hypercalcaemic patients.
Running costs
From list supplied byUK distributors inJanuary 1987:
Total running costs during the evaluation 825
Total samples analysed 1670
i.e. cost per sample 42p
Basic costs: running the instrument per annum without
warranty, for maintenance alone 1221.06. Calibra-
tion costs: varying daily frequency of calibration.
x 1/24h x 3/24h x 12/24h
130 460 1450
Eight-hourly calibrations would be required for
reasonable precision.
Sample costs: without maintenance of calibration.
Reagent pack for 500 samples 130-500 26p
iCa electrode for 600 samples 30-600 5"8p
Total 31.8p
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Projected cost per sampl-e:
For 5000 samples per annum with 8 hourly calibration:
Maintenance costs
Calibration costs
Divided by number of samples
Plus cost per sample (q.v.)
1221"60
460"00
Total 1681"60
"336
"318
TOtal 65.4p
For 10 000 samples per annum with 8 hourly calibration:
Maintenance & calibration costs 1681.60
Divided by number of samples 168
Plus cost per sample (q.v.) "318
Total 48"6p
User appraisal
The instrument proved to be robust and reliable, and
performed well both in high throughput situations and as
a stat analyser. All stafffound it easy to use. Maintenance
procedures were straightforward and simple, and the
instruction manual was clear and easy to follow. The
manual supplied with the instrument was comprehen-
sive.
Users found the error codes confusing, in that the
difference between major error codes which need opera-
tor intervention, and minor error codes, which only
indicate a warning signal, but do not require operator
intervention, are not clearly differentiated. The flashing
light should be reserved for the major error codes only.
This would provide a useful indication to the operator as
to when actual intervention, rather than merely a general
alertness, was required.
Discussion
The NSPI showed good performance for bias and
precision, not only for the manufacturer’s control
material, where similar or better precision to that claimed
by previous workers was recorded (7), but also for
tonometered whole blood. Patient sample comparison
showed good agreement for pH and blood gases, sodium
and potassium measurements. Hct comparison with
patient samples showed less good agreement.
During the evaluation, the NSPI had to be moved three
times because of departmental changes; handling was
carried out each time by the UK agent, and the
instrument’s performance was unaffected. At the first
site, the microprocessor on the NSPI was found to be
sensitive to voltage surges occurring from mobile X-ray
equipment, necessitating repeated ’set-up’ procedures. A
voltage stabilizer (spike smoother) was attached to the
instrument, and no further problems occurred. The
instrument conforms to ESCHLE requirements (Elec-
trical Safety Code for Hospital Laboratory Equipment),
and interfaces with RS 232 and Modem.
The cost of using the instrument varies depending on the
workload each day, and cost per sample decreases with
increased sample throughput. With the option ofrunning
fewer autocalibrations, more samples can be run from one
reagent pack. Projected costs based on reduced number of
daily autocalibrations show a corresponding decrease in
cost per sample. The manufacturer is introducing options
for reducing the number of autocalibrations per day.
Override may be operated on autocalibrations for up to
30 min.
Ionized calcium
The addition of ionized calcium to the range of tests
provided was felt to be a useful adjunct. Many areas of
potential use have been listed for iCa measurement. [2
and 10], including the care of the multiply transfused,
diagnosis and management of parathyroid disease, in
patients with abnormal serum proteins and in liver
transplantation. The reliability of the NSPI’s iCa elec-
trode, together with the built-in maintenance and perfor-
mance control from the autocal programme, offer a
convenient and reliable method for determining calcium
status [8]. This is particularly so when sample handling
for iCa analysis in samples other than arterial blood
requires some care. [6, 9].
Plasma samples were shown to need centrifuging and
analysis within one hour of being taken. Sample bottles
should be filled as completely as possible to minimize the
effects of both carbon dioxide loss and anticoagulant
complexing. Appreciable error (see Figure 3) can be
caused by the latter, which also affected potassium
measurements.
In the hypercalcaemic patients, it can be seen that there is
no consistent relation between the iCa and tCa levels
above the upper limit of normal. However, a correlation
between serum iCa and albumin concentration similar to
that observed by other workers was noted [10].
With the proviso that special precautions should be taken
to avoid artefacts which might give rise to the reporting of
erroneous iCa results, iCa measurement satisfies a
particular need in patient management. A blood gas and
electrolyte analyser combines sample requirements, and
with its in-built monitoring and calibration facilities
offers a reliable and rapid service.
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FEBRUARY
8-9 February 1989 Flow Analysis Methods: London, UK.
Contact Analytical Division, RSC, Burlington House,
Piccadilly, London W1V 0BN.
MARCH
6-10 March 1989 Pittsburgh Conference 1989: Atlanta, GA,
USA. Contact Pittsburgh Conference, Suite 322, 12
Federal Drive, Pittsburgh, PA 15235, USA.
7-9 March 1989 Workshop: Statisticsfor Analytica.l Chemists:
Eastbourne, UK. Contact Christine Robinson, Statistics for
Industry (UK) Ltd, 4 Victoria Avenue, Knaresborough,
North Yorks HGF 9EU, UK.
21-22 March 1989 Research and Development Topics in
Analytical Chemistry: Dublin, Ireland. Contact Analytical
Division, Royal Society ofChemistry, Burlington House,
Piccadilly, London W1V 0BN.
APRIL
4-7 April 1989 RSC Annual Congress: Hull, UK. Contact
Gina B. Howlett, Conference Officer, RSC, Burlington
House, Piccadilly, London N1V 0BN. The Analytical
Division session will be on Process Analysis and Information
Management.
11-14 April 1989 VIIth International Symposium on Electro-
analysis and Sensors in Biomedical, Environmental and Industrial
Sciences: Loughborough, UK. Contact Dr A. G. Fogg,
Chemistry Department, University of Loughborough,
Leicestershire LE11 3TU.
JUNE
25-30 June 1989 Eurosensors III and 5th International
Conference on Sensors and Actuators: Montreux, Switzerland.
Contact Eurosensors (Transducers ’89), COMST S.A.,
PO Box 415, 1001 Lausanne 1, Switzerland.
JULY
30 July-5 August 1989 SAC 89." Cambridge, UK. Contact
Analytical Division, Royal Society ofChemistry, Burling-
ton House, Piccadilly, London W1V 0BN.
SEPTEMBER
11-13 September 1989 RSC/SCI/IOP Joint International
Symposium on Surface Analysis Techniques and Applications:
Manchester, UK. Contact Mrs E. S. Wellingham, Field
End House, Bude Close, Nailsea, Bristol BS19 2FQ.
25-27 September 1989 Sensors and their Applications IV:
Canterbury, UK. The Meetings Officer, Institute of
Physics, 47 Belgrave Square, London SWlX 8QX.
25-28 September 1989 Third International Symposium on
Kinetics in Analytical Chemistry: Dubrovnik, Yugoslavia. Con-
tact Professor Gordana A. Milonovi. Department of
Chemistry, University of Belgrade, KAC PO Box 550,
11001 Belgrade, Yugoslavia.
26-28 September 1989 The British Laboratory Week:
Olympia, London. Including Laboratory 89, Computer
Aided Sciences, Bio 89, Medical Laboratory Sciences and
Analyticon. Contact Curtis Steadman and Partners, The
Hub, Emson Close, Saffron Walden, Essex CB10 1HL.
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